How Thermo Fisher Scientific Beat Wall Street Estimates in Q4

How Thermo Fisher Scientific Beat Wall Street Estimates in Q4

Source: 
Motley Fool
snippet: 

Problems come joined at the hip with opportunities. Thermo Fisher Scientific (NYSE:TMO) has definitely found that to be the case with the COVID-19 pandemic. The company's growth has accelerated and its stock has soared over the last 12 months thanks primarily to coronavirus testing.